Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
American Battery Technology Co
ABAT
$344M
| $632K | ﹤0.01% |
189,157
+64,297
| +51% | +$301K |
|
|
FNGU
3677
MicroSectors FANG+ 3x Leveraged ETNs due Feb 17 2045
FNGU
$2.69B
| $630K | ﹤0.01% |
24,600
-5,000
| -17% | -$144K |
|
3678
Direxion Daily GOOGL Bull 2X ETF
GGLL
$957M
| $630K | ﹤0.01% |
+6,500
| New | +$553K |
|
3679
CALL
S&P Global
SPGI
$122B
| $627K | ﹤0.01% |
1,200
-17,900
| -94% | -$8.86M |
|
3680
Community Health Systems
CYH
$415M
| $623K | ﹤0.01% |
199,793
+16,639
| +9% | +$56K |
|
3681
KE Holdings
BEKE
$18.7B
| $623K | ﹤0.01% |
39,528
+14,487
| +58% | +$249K |
|
3682
Alector
ALEC
$224M
| $622K | ﹤0.01% |
398,687
-474,688
| -54% | -$842K |
|
3683
CALL
Autodesk
ADSK
$52B
| $622K | ﹤0.01% |
2,100
| – | – |
|
3684
Park Aerospace
PKE
$816M
| $620K | ﹤0.01% |
29,043
+3,303
| +13% | +$65.8K |
|
3685
Home Bancorp
HBCP
$568M
| $615K | ﹤0.01% |
10,644
+1,061
| +11% | +$59.1K |
|
3686
Wabash National
WNC
$527M
| $613K | ﹤0.01% |
70,893
+3,479
| +5% | +$30.4K |
|
3687
Critical Metals Corp
CRML
$971M
| $613K | ﹤0.01% |
88,287
+40,709
| +86% | +$444K |
|
3688
Riley Exploration Permian
REPX
$780M
| $612K | ﹤0.01% |
23,177
+4,248
| +22% | +$113K |
|
3689
ECARX Holdings
ECX
$413M
| $610K | ﹤0.01% |
354,529
-3,038,500
| -90% | -$6.16M |
|
3690
CALL
Keysight
KEYS
$60.9B
| $610K | ﹤0.01% |
3,000
| – | – |
|
|
NLOP
3691
Net Lease Office Properties
NLOP
$173M
| $608K | ﹤0.01% |
23,573
+1,861
| +9% | +$52.6K |
|
3692
Foster
FSTR
$404M
| $607K | ﹤0.01% |
22,517
+1,513
| +7% | +$40.8K |
|
3693
PUT
Krispy Kreme
DNUT
$581M
| $603K | ﹤0.01% |
+150,000
| New | +$594K |
|
3694
Kelly Services Class A
KELYA
$545M
| $602K | ﹤0.01% |
68,450
+977
| +1% | +$9.93K |
|
3695
Methode Electronics
MEI
$615M
| $600K | ﹤0.01% |
90,325
+3,906
| +5% | +$27.7K |
|
3696
First Internet Bancorp
INBK
$258M
| $599K | ﹤0.01% |
28,685
+1,141
| +4% | +$22.9K |
|
3697
Eve Holding
EVEX
$965M
| $597K | ﹤0.01% |
149,612
+76,560
| +105% | +$337K |
|
|
BBBY
3698
Bed Bath & Beyond
BBBY
$418M
| $595K | ﹤0.01% |
108,932
+21,339
| +24% | +$155K |
|
3699
CALL
Centene
CNC
$32.9B
| $593K | ﹤0.01% |
14,400
-33,600
| -70% | -$1.26M |
|
3700
Rayonier Advanced Materials
RYAM
$570M
| $592K | ﹤0.01% |
100,484
+4,348
| +5% | +$28.3K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.